Cardiovascular disease remains the principal cause of death and disability among patients
with diabetes mellitus. Diabetes mellitus exacerbates mechanisms underlying …

Cardiovascular diseases (CVD), including heart and pathological circulatory conditions, are
the world's leading cause of mortality and morbidity. Endothelial dysfunction involved in …

Background Diabetes mellitus is a well-known risk factor for the development of heart failure.
Inflammation and oxidative stress play a key role in the development of diabetic …

Ischemic heart disease (IHD) is commonly recognized as the consequence of coronary
atherosclerosis and obstructive coronary artery disease (CAD). However, a significant …

Sodium glucose cotransporter 2 inhibitors (SGLT2i) are the first antidiabetic compounds that
effectively reduce heart failure hospitalization and cardiovascular death in type 2 diabetics …

Diabetes is a recognized risk factor for cardiovascular diseases and heart failure. Diabetic
cardiovascular dysfunction also underscores the development of diabetic retinopathy …

Diabetic cardiomyopathy is a common cardiac condition in patients with diabetes mellitus,
which can result in cardiac hypertrophy and subsequent heart failure, associated with …

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral glucose-lowering
agents. Apart from their glucose-lowering effects, large clinical trials assessing certain …

The significance, mechanisms and consequences of coronary microvascular dysfunction
associated with diabetes mellitus are topics into which we have insufficient insight at this …

Andrographolide (Andr) is a major component isolated from the plant Andrographis
paniculata. Inflammation, apoptosis, and impaired angiogenesis are implicated in the …